- Author:
Ying-Ying TIAN
1
;
Ai-Lin YANG
1
;
Xiao-Nan CHEN
1
;
Jia-Qi LI
1
;
Lei-Meng-Yuan TANG
1
;
Hui-Ming HUANG
1
;
Ya-Xin LIU
1
;
Hai-Ling QIU
1
;
Li-Shan OUYANG
1
;
Jun LI
1
;
Peng-Fei TU
1
;
Zhong-Dong HU
1
Author Information
- Publication Type:Journal Article
- Keywords: Chinese dragon′s blood; anti-tumor; mechanism
- MeSH: China; Dracaena; Female; Plant Extracts; Resins, Plant
- From: China Journal of Chinese Materia Medica 2021;46(8):2037-2044
- CountryChina
- Language:Chinese
- Abstract: As a traditional Chinese medicine, Chinese dragon's blood has multiple effects, such as activating blood to remove blood stasis, softening and dispelling stagnation, astringent and hemostasis, clearing swelling and relieving pain, regulating menstruation and rectifying the blood, so it is called "an effective medicine of promoting blood circulation". It has been widely used clinically to treat a variety of diseases. With the further research on Chinese dragon's blood, its anti-tumor medicinal value is gradually emerging. Modern pharmacological studies have shown that Chinese dragon's blood exerts anti-tumor effects mainly by inhibiting cell proliferation, inducing apoptosis, inducing DNA damage and cell cycle arrest, inducing senescence and autophagy of tumor cells, inhibiting metastasis and angiogenesis, as well as reversing multidrug resistance. This article focuses on the research progress on anti-tumor effects of Chinese dragon's blood extract and its chemical components, with a view to provide new references for the in-depth research and reasonable utilization of Chinese dragon's blood.